Correlation Between Cabaletta Bio and Viking Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cabaletta Bio and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabaletta Bio and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cabaletta Bio and Viking Therapeutics, you can compare the effects of market volatilities on Cabaletta Bio and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabaletta Bio with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabaletta Bio and Viking Therapeutics.

Diversification Opportunities for Cabaletta Bio and Viking Therapeutics

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cabaletta and Viking is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Cabaletta Bio and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Cabaletta Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabaletta Bio are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Cabaletta Bio i.e., Cabaletta Bio and Viking Therapeutics go up and down completely randomly.

Pair Corralation between Cabaletta Bio and Viking Therapeutics

Given the investment horizon of 90 days Cabaletta Bio is expected to under-perform the Viking Therapeutics. In addition to that, Cabaletta Bio is 1.08 times more volatile than Viking Therapeutics. It trades about -0.16 of its total potential returns per unit of risk. Viking Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest  3,486  in Viking Therapeutics on January 15, 2025 and sell it today you would lose (1,029) from holding Viking Therapeutics or give up 29.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Cabaletta Bio  vs.  Viking Therapeutics

 Performance 
       Timeline  
Cabaletta Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cabaletta Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Viking Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cabaletta Bio and Viking Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cabaletta Bio and Viking Therapeutics

The main advantage of trading using opposite Cabaletta Bio and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabaletta Bio position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.
The idea behind Cabaletta Bio and Viking Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments